Richard J Mark insider trades: Tenet Healthcare (THC) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Richard reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 10, 2026 | THC | ↓ Sell | 10,000 | $263.42 | $2.6M | Direct | Sep 14, 2026 (4d) |
| Mar 11, 2026 | SRE | ↑ Buy | 2,692 | $93.30 | $251K | Direct | Mar 11, 2026 (0d) |
| Mar 6, 2025 | SRE | ↑ Buy | 7,160 | $69.81 | $500K | Direct | Mar 7, 2025 (1d) |
| May 17, 2024 | SRE | ↑ Buy | 1,925 | $77.97 | $150K | Direct | May 17, 2024 (0d) |
| Mar 12, 2024 | THC | ↓ Sell | 14,000 | $98.98 | $1.4M | Direct | Mar 14, 2024 (2d) |
| Mar 31, 2022 | AEE | ↓ Sell10b5-1 | 6,000 | $93.67 | $562K | Direct | Apr 4, 2022 (4d) |
| Mar 10, 2022 | AEE | ↓ Sell | 3,500 | $87.37 | $306K | Direct | Mar 14, 2022 (4d) |
| Mar 9, 2022 | THC | ↓ Sell | 6,000 | $90.47 | $543K | Direct | Mar 10, 2022 (1d) |
| Sep 30, 2021 | AEE | ↓ Sell10b5-1 | 6,000 | $82.18 | $493K | Direct | Mar 2, 2022 (153d) |
| Mar 31, 2021 | AEE | ↓ Sell10b5-1 | 6,000 | $81.17 | $487K | Direct | Apr 2, 2021 (2d) |
| Nov 19, 2020 | AEE | ↓ Sell | 6,300 | $78.00 | $491K | Direct | Nov 23, 2020 (4d) |
| Jun 2, 2016 | AEE | ↓ Sell | 9,300 | $48.89 | $455K | Direct | Jun 6, 2016 (4d) |
| Nov 25, 2009 | AEE | ↓ Sell | 1,907 | $25.91 | $49K | Direct | Nov 30, 2009 (5d) |
| Nov 15, 2007 | AEE | ↓ Sell | 3,574 | $52.27 | $187K | Direct | Nov 19, 2007 (4d) |
| May 31, 2005 | AEE | ↑ Buy | 183 | $54.63 | $10K | Direct | Jun 6, 2005 (6d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other THC insiders
Open-market trades in the last 12 months
About Richard J Mark's insider trades
Richard J Mark is an insider at Tenet Healthcare (THC). Since May 31, 2005, Richard has reported 4 open-market purchases worth $911K and 11 sales worth $7.6M on SEC Form 4. In the last 12 months: 1 buy ($251K) and 1 sale ($2.6M).
3 sales (20% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (43 filings), shares withheld for taxes (21 filings), option exercises (8 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every THC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.